- Home
- ROOT vs MLTX Comparison
ROOT vs MLTX Comparison
Compare ROOT & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$15.30
Company Overview
Basic Information| Metric | ROOT | MLTX |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ROOT | MLTX |
|---|---|---|
| Price | $61.44 | $15.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $121.60 | $22.22 |
| AVG Volume (30 Days) | 275.6K | ★ 3.5M |
| Earning Date | 02-25-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 3.34 | N/A |
| Revenue | ★ $1,446,800,000.00 | N/A |
| Revenue This Year | $29.96 | N/A |
| Revenue Next Year | $5.89 | N/A |
| P/E Ratio | $18.51 | ★ N/A |
| Revenue Growth | ★ 38.50 | N/A |
| 52 Week Low | $60.10 | $5.95 |
| 52 Week High | $181.14 | $62.75 |
Technical Indicators
Market Signals| Indicator | ROOT | MLTX |
|---|---|---|
| Relative Strength Index (RSI) | 30.80 | 49.14 |
| Support Level | $60.10 | $15.62 |
| Resistance Level | $65.81 | $16.69 |
| Average True Range (ATR) | 3.14 | 0.90 |
| MACD | -0.74 | -0.14 |
| Stochastic Oscillator | 9.80 | 5.07 |
Price Performance
Historical Comparison ROOT
MLTX
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.